▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

IPG Photonics Q4 21 Earnings Conference Call At 10:00 AM ET

By RTTNews Staff Writer ✉ | Published: 2/15/2022 6:00 AM ET

IPG Photonics Corporation (IPGP) will host a conference call at 10:00 AM ET on February 15, 2022, to discuss Q4 21 earnings results.

To access the live webcast, log on to https://investor.ipgphotonics.com/overview/default.aspx

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In December 2022

Biotech Stocks Facing FDA Decision In December 2022

Biotech Stocks Facing FDA Decision In November 2022

Biotech Stocks Facing FDA Decision In November 2022

Biotech Stocks Facing FDA Decision In October 2022

Biotech Stocks Facing FDA Decision In October 2022

Latest Updates on COVID-19

U.S. Covid Cases And Casualties Continue To Rise

US Covid Cases And Casualties Rising Again

U.S. Reports 52,503 New Covid Cases, 439 Deaths

U.S. Covid Casualties Fall 11% In In A Fortnight

11% Fall In US Covid Casualties In A Fortnight

Read More

COVID-19: Drugs in Development

RELATED NEWS

IPG Photonics Q3 22 Earnings Conference Call At 10:00 AM ET

IPG Photonics Q3 Profit Increases

Follow RTT

Editor's Pick
Most Read
Most Emailed

Black Friday Online Sales Reach $9.12 Bln

Weis Markets Recalls Sea Salt And Caramel Ripple Ice Cream

Amazon Likely To Invest $1 Bln A Year In Movies To Release In Theaters

Bentex Recalls Children's Clothing Sets

UK Probes Apple And Google's Control Over Web Browsing

AbbVie: SKYRIZI (risankizumab) Gets EU Approval To Treat Moderate To Severe Active Crohn's Disease

Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab

FDA Rejects Spectrum's Poziotinib, As Expected, Company To Cut R&D Workforce By 75%

BioMarin: FDA No Longer Plans To Hold Advisory Committee Meeting To Discuss BLA

Ascletis Pharma : FDA Approves IND Of Oral 3CLpro Inhibitor ASC11 For COVID-19

Sandvik Receives Mining Equipment Order In Democratic Republic Of Congo

Adidas Launches Investigation Into Intimidation Allegations Against Kanye West: Report

Biotech Stocks Facing FDA Decision In December 2022

SARIA Nederland To Acquire Devro

Johnson Matthey H1 Underlying Operating Profit Declines; Revenue Down 14%

SNC-Lavalin Gets $62 Mln US Contract To Relocate And Equip U.S. Military Hospital

Amazon Likely To Invest $1 Bln A Year In Movies To Release In Theaters

Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab

Barclays CEO To Undergo Treatment For Non-Hodgkin Lymphoma

Metals Acquisition, Glencore Agree To Amend Terms To Acquire Cobar Mine

SuperCom Board, Stockholders Approve 1-for-10 Reverse Stock Split - Quick Facts

C4X Discovery Inks Licensing Deal Worth Up To $402 Mln With AstraZeneca

Anglo American, Aurubis Join To Develop Assurance On Sustainable Copper Value Chain

United Utilities H1 Pre-tax Earnings Rise, But Sales Fall

1&1, Orange Conclude Agreement On International Roaming - Quick Facts

BioMarin: FDA No Longer Plans To Hold Advisory Committee Meeting To Discuss BLA

Biotech Stocks Facing FDA Decision In December 2022

Weis Markets Recalls Sea Salt And Caramel Ripple Ice Cream

SARIA Nederland To Acquire Devro